- Home
- ACXP vs IRIX Comparison
ACXP vs IRIX Comparison
Compare ACXP & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- IRIX
- Stock Information
- Founded
- ACXP 2017
- IRIX 1989
- Country
- ACXP United States
- IRIX United States
- Employees
- ACXP N/A
- IRIX N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ACXP Health Care
- IRIX Health Care
- Exchange
- ACXP Nasdaq
- IRIX Nasdaq
- Market Cap
- ACXP 31.4M
- IRIX 27.5M
- IPO Year
- ACXP 2021
- IRIX 1996
- Fundamental
- Price
- ACXP $0.78
- IRIX $1.51
- Analyst Decision
- ACXP Strong Buy
- IRIX Hold
- Analyst Count
- ACXP 1
- IRIX 1
- Target Price
- ACXP $12.00
- IRIX $2.00
- AVG Volume (30 Days)
- ACXP 132.1K
- IRIX 30.8K
- Earning Date
- ACXP 03-14-2025
- IRIX 03-25-2025
- Dividend Yield
- ACXP N/A
- IRIX N/A
- EPS Growth
- ACXP N/A
- IRIX N/A
- EPS
- ACXP N/A
- IRIX N/A
- Revenue
- ACXP N/A
- IRIX $48,431,000.00
- Revenue This Year
- ACXP N/A
- IRIX N/A
- Revenue Next Year
- ACXP N/A
- IRIX $5.44
- P/E Ratio
- ACXP N/A
- IRIX N/A
- Revenue Growth
- ACXP N/A
- IRIX N/A
- 52 Week Low
- ACXP $0.67
- IRIX $1.27
- 52 Week High
- ACXP $3.35
- IRIX $3.65
- Technical
- Relative Strength Index (RSI)
- ACXP 49.91
- IRIX 38.42
- Support Level
- ACXP $0.67
- IRIX $1.46
- Resistance Level
- ACXP $0.76
- IRIX $1.60
- Average True Range (ATR)
- ACXP 0.04
- IRIX 0.05
- MACD
- ACXP 0.00
- IRIX -0.01
- Stochastic Oscillator
- ACXP 75.28
- IRIX 18.75
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.